|
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseDiscovery |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
MechanismCYP11A1 inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhaseDiscovery |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
|
|
|
|
Inactive Indication- |
Drug Highest PhaseDiscovery |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Shanghai Wennai Pharmaceutical Technology Co., Ltd.
0 Patents (Medical) associated with Shanghai Wennai Pharmaceutical Technology Co., Ltd.
100 Deals associated with Shanghai Wennai Pharmaceutical Technology Co., Ltd.
100 Translational Medicine associated with Shanghai Wennai Pharmaceutical Technology Co., Ltd.